Objective: The authors provide an evidenced-based summary of the literature on the clinical
application of psychedelic drugs in psychiatric disorders. Methods: Searches of PubMed and …

Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

Lysergic acid diethylamide (LSD) is a classic psychedelic, 3, 4-
methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a …

Objectives To explore feasibility and safety of MDMA-assisted psychotherapy for reduction of
social fear and avoidance that are common in the autistic population. Methods Autistic adults …

Unsuccessfully treated posttraumatic stress disorder (PTSD) is a serious and life-threatening
disorder. Two medications, paroxetine hydrochloride and sertraline hydrochloride, are …

Case reports indicate that psychiatrists administered±3, 4-
methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before …

The success of modern medicine creates a growing population of those suffering from life-
threatening illnesses (LTI) who often experience anxiety, depression, and existential …

We report follow-up data evaluating the long-term outcomes for the first completed trial of 3,
4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for chronic, treatment …

MDMA-assisted psychotherapy for treatment of PTSD has recently progressed to Phase 3
clinical trials and received Breakthrough Therapy designation by the FDA. MDMA used as …

phosphorloxy-N, N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine
(MDMA), best known for their illegal use as psychedelic drugs, are showing promise as …